◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

NervGen Pharma Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Selling General And Administration 1.7M 3.8M 2.9M 2.2M 2.8M --
General And Administrative Expense 1.7M 3.8M 2.9M 2.2M 2.8M --
Research And Development 4.4M 2.7M 3.1M 4.6M 4.4M --
Depreciation And Amortization In Income Statement 0.00 0.00 0.00 1,863 703.00 --
Operating Expense 6.2M 6.5M 6.0M 6.8M 7.2M --
Operating Income -6.2M -6.5M -6.0M -6.8M -7.2M --
EBIT -6.2M -6.5M -6.0M -6.8M -7.2M --
Interest Income 77,071 86,904 107,761 171,110 243,679 --
Interest Income Non Operating 77,071 86,904 107,761 171,110 243,679 --
Net Interest Income 77,071 86,904 107,761 171,110 243,679 --
Other Income Expense 1.9M -2.7M 2.0M -2.0M 1.7M --
Gain On Sale Of Security 1.9M -2.7M 2.0M -2.0M 1.7M --
Pretax Income -4.2M -9.1M -3.9M -8.6M -5.3M --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -4.2M -9.1M -3.9M -8.6M -5.3M --
Net Income From Continuing Operation Net Minority Interest -4.2M -9.1M -3.9M -8.6M -5.3M --
Net Income Including Noncontrolling Interests -4.2M -9.1M -3.9M -8.6M -5.3M --
Net Income Common Stockholders -4.2M -9.1M -3.9M -8.6M -5.3M --
Net Income -4.2M -9.1M -3.9M -8.6M -5.3M --
EBITDA -6.2M -6.5M -6.0M -6.8M -7.2M --
Normalized EBITDA -8.1M -3.7M -8.0M -4.8M -8.9M --
Reconciled Depreciation 13,949 13,948 13,949 15,811 14,652 --
Basic EPS -0.06 -0.13 -0.06 -- -0.08 -0.11
Diluted EPS -0.06 -0.13 -0.06 -- -0.08 -0.11
Basic Average Shares 73.2M 72.0M 70.7M -- 70.1M 70.0M
Diluted Average Shares 73.2M 72.0M 70.7M -- 70.1M 70.0M
Total Unusual Items 1.9M -2.7M 2.0M -2.0M 1.7M --
Total Unusual Items Excluding Goodwill 1.9M -2.7M 2.0M -2.0M 1.7M --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -6.1M -6.4M -5.9M -6.6M -7.0M --
Depreciation Amortization Depletion Income Statement 0.00 0.00 0.00 1,863 703.00 --
Depreciation Income Statement 0.00 0.00 0.00 1,863 703.00 --
Diluted NI Availto Com Stockholders -4.2M -9.1M -3.9M -8.6M -5.3M --
Net Income Continuous Operations -4.2M -9.1M -3.9M -8.6M -5.3M --
Net Non Operating Interest Income Expense 77,071 86,904 107,761 171,110 243,679 --
Other Gand A 627,861 1.1M 999,989 542,501 925,149 --
Salaries And Wages 1.1M 2.7M 1.9M 1.7M 1.9M --
Total Expenses 6.2M 6.5M 6.0M 6.8M 7.2M --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 11.4M 15.7M 14.5M 17.3M 21.0M --
Cash Cash Equivalents And Short Term Investments 11.4M 15.7M 14.6M 17.4M 21.0M --
Other Short Term Investments 33,225 57,713 81,838 97,234 -- --
Accounts Receivable -- -- -- -- 6,437 11,549
Receivables 344,205 96,954 333,766 415,301 102,227 --
Prepaid Assets 601,686 364,155 433,263 716,951 834,073 --
Other Current Assets 22,528 45,056 67,584 105,664 -- --
Current Assets 12.7M 16.5M 15.4M 19.0M 21.9M --
Gross PPE -- -- -- 0.00 1,863 2,566
Net PPE -- -- -- 0.00 1,863 2,566
Goodwill And Other Intangible Assets 423,112 437,061 451,009 464,958 478,906 --
Other Intangible Assets 423,112 437,061 451,009 464,958 478,906 --
Investments And Advances 0.00 0.00 0.00 8,369 -- --
Other Investments 0.00 0.00 0.00 8,369 -- --
Total Non Current Assets 423,112 437,061 451,009 473,327 513,995 --
Total Assets 13.1M 16.9M 15.8M 19.5M 22.5M --
Current Debt And Capital Lease Obligation 33,225 57,713 81,838 97,234 95,790 --
Accounts Payable -- -- -- -- 457,289 559,451
Payables 38,800 39,167 38,588 33,439 1.0M --
Payables And Accrued Expenses 4.4M 4.2M 3.9M 3.8M 3.4M --
Current Accrued Expenses 4.3M 4.1M 3.8M 3.7M 2.4M --
Other Current Liabilities 10.6M 12.6M 9.9M 11.9M 9.8M --
Current Liabilities 16.0M 17.8M 14.4M 16.9M 13.2M --
Long Term Debt And Capital Lease Obligation 0.00 0.00 0.00 8,369 33,226 --
Long Term Capital Lease Obligation 0.00 0.00 0.00 8,369 33,226 --
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 8,369 33,226 --
Total Liabilities Net Minority Interest 16.0M 17.8M 14.4M 16.9M 13.3M --
Common Stock 90.5M 88.4M 82.4M 81.1M 80.5M --
Capital Stock 90.5M 88.4M 82.4M 81.1M 80.5M --
Retained Earnings -119.9M -115.2M -106.1M -102.2M -93.6M --
Gains Losses Not Affecting Retained Earnings 26.4M 25.9M 25.1M 23.6M 22.2M --
Common Stock Equity -2.9M -918,421 1.4M 2.6M 9.2M --
Stockholders Equity -2.9M -918,421 1.4M 2.6M 9.2M --
Total Equity Gross Minority Interest -2.9M -918,421 1.4M 2.6M 9.2M --
Total Capitalization -2.9M -918,421 1.4M 2.6M 9.2M --
Net Tangible Assets -3.4M -1.4M 938,468 2.1M 8.7M --
Tangible Book Value -3.4M -1.4M 938,468 2.1M 8.7M --
Working Capital -3.4M -1.4M 938,468 2.1M 8.7M --
Invested Capital -2.9M -918,421 1.4M 2.6M 9.2M --
Total Debt 33,225 57,713 81,838 105,603 129,016 --
Share Issued 73.4M 72.8M 70.9M 70.3M 70.2M --
Ordinary Shares Number 73.4M 72.8M 70.9M 70.3M 70.2M --
Capital Lease Obligations 33,225 57,713 81,838 105,603 129,016 --
Current Capital Lease Obligation 33,225 57,713 81,838 97,234 95,790 --
Current Deferred Assets 288,641 248,073 0.00 410,257 -- --
Dueto Related Parties Current -- -- -- -- 578,830 2.8M
Non Current Accounts Receivable -- -- -- -- 33,226 57,713
Other Payable 38,800 39,167 38,588 33,439 -- --
Other Properties -- -- -- -- 1,863 2,566
Other Receivables 287,144 25,315 202,922 270,645 95,790 --
Pensionand Other Post Retirement Benefit Plans Current 1.0M 1.1M 636,246 1.2M -- --
Taxes Receivable 57,061 71,639 130,844 144,656 -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -5.3M -3.7M -4.1M -3.7M -5.8M --
Cash Flow From Continuing Operating Activities -5.3M -3.7M -4.1M -3.7M -5.8M --
Depreciation And Amortization 13,949 13,948 13,949 15,811 14,652 --
Depreciation Amortization Depletion 13,949 13,948 13,949 15,811 14,652 --
Stock Based Compensation 1.1M 2.0M 1.5M 1.7M 1.9M --
Change In Working Capital -298,913 793,527 355,545 743,292 -495,149 --
Changes In Account Receivables -- 236,812 81,535 -408,864 5,112 2,027
Change In Receivables -247,251 236,812 81,535 -408,864 5,112 --
Change In Payables And Accrued Expense 203,907 713,154 -458,015 1.2M -335,343 --
Change In Payable -- -- -- -- -335,343 --
Other Non Cash Items -- -- -- -1.00 1.00 6,944
Purchase Of PPE -- -- -- 0.00 0.00 --
Net PPE Purchase And Sale -- -- -- 0.00 -8,411 0.00
Investing Cash Flow 25,232 25,231 25,232 25,232 25,231 --
Cash Flow From Continuing Investing Activities 25,232 25,231 25,232 25,232 25,231 --
Repayment Of Debt -25,232 -25,231 -25,232 -25,231 -25,232 --
Net Issuance Payments Of Debt -25,232 -25,231 -25,232 -25,231 -25,232 --
Issuance Of Capital Stock 1.00 1.1M 1.6M 0.00 0.00 --
Net Common Stock Issuance 1.00 1.1M 1.6M 0.00 0.00 --
Financing Cash Flow 995,203 4.8M 1.3M 310,000 269,737 --
Cash Flow From Continuing Financing Activities 995,203 4.8M 1.3M 310,000 269,737 --
Effect Of Exchange Rate Changes -12,954 90,659 22,884 -416,189 -93,555 --
Changes In Cash -4.3M 1.1M -2.8M -3.3M -5.5M --
Beginning Cash Position 15.7M 14.5M 17.3M 21.0M 26.6M --
End Cash Position 11.4M 15.7M 14.5M 17.3M 21.0M --
Free Cash Flow -5.3M -3.7M -4.1M -3.7M -5.8M --
Interest Paid Supplemental Data 0.00 0.00 0.00 0.00 0.00 --
Amortization Cash Flow 13,949 13,948 13,949 13,948 13,949 --
Amortization Of Intangibles 13,949 13,948 13,949 13,948 13,949 --
Change In Account Payable -- -- -- -- -335,343 --
Change In Prepaid Assets -255,569 -156,439 732,025 -9,733 -164,918 --
Common Stock Issuance 1.00 1.1M 1.6M 0.00 0.00 --
Depreciation 0.00 0.00 0.00 1,863 703.00 --
Gain Loss On Investment Securities -2.0M 2.7M -2.0M 2.1M -1.8M --
Gain Loss On Sale Of PPE 0.00 -- -- 0.00 0.00 --
Long Term Debt Payments -25,232 -25,231 -25,232 -25,231 -25,232 --
Net Foreign Currency Exchange Gain Loss -5,912 -83,826 -5,040 414,811 93,555 --
Net Income From Continuing Operations -4.2M -9.1M -3.9M -8.6M -5.5M --
Net Intangibles Purchase And Sale -- -- 25,232 25,232 25,231 8,411
Net Long Term Debt Issuance -25,232 -25,231 -25,232 -25,231 -25,232 --
Net Other Financing Charges -80,575 -144,616 -460,153 0.00 19.00 --
Operating Gains Losses -2.0M 2.6M -2.0M 2.5M -1.7M --
Proceeds From Stock Option Exercised 1.1M 3.8M 120,000 335,231 294,950 --
Purchase Of Intangibles -- -- -- 0.00 -- --
Sale Of Intangibles -- -- 25,232 25,232 25,231 8,411
Sale Of PPE -- -- -- 0.00 -8,411 0.00
NEWS
Loading news...
TRENDING
Loading...